Discover how Artificial Intelligence is revolutionizing the field of cardiology, offering new perspectives and solutions that were once considered impossible.
The ICI Meeting 2024 is an acclaimed forum which aims to explore fuel, spark and be involved in the innovations that will shape the future of our cardiovascular systems.
Lupus, doctors like to say, affects no two patients the same. The disease causes the immune system to go rogue in a way that can strike virtually any organ in the body, but when and where is maddeningly elusive. One patient might have lesions on the face, likened to wolf bites by the 13th-century physician who gave lupus its name. Another patient might have kidney failure. Another, fluid around the lungs. What doctors can say to every patient, though, is that they will have lupus for the rest of their life. The origins of autoimmune diseases like it are often mysterious, and an immune system that sees the body it inhabits as an enemy will never completely relax. Lupus cannot be cured. No autoimmune disease can be cured.
Two years ago, however, a study came out of Germany that rocked all of these assumptions. Five patients with uncontrolled lupus went into complete remission after undergoing a repurposed cancer treatment called CAR-T-cell therapy, which largely wiped out their rogue immune cells. The first treated patient has had no symptoms for almost four years now. ‘We never dared to think about the cure for our disease,’ says Anca Askanase, a rheumatologist at Columbia University’s medical center who specializes in lupus. But these stunning results—remission in every patient—have fueled a new wave of optimism. More than 40 people with lupus worldwide have now undergone CAR-T-cell therapy, and most have gone into drug-free remission. It is too early to declare any of these patients cured for life, but that now seems within the realm of possibility.
From The Atlantic.
Mint’s All About AI Tech4Good Awards recognised impactful AI solutions at the Jio World Centre in Mumbai. The event emphasised purpose-driven innovation, with discussions on ethical AI and community empowerment, showcasing how technology can address pressing social and environmental issues.
Chimeric antigen receptor T-cell (CAR-T) therapy, already approved for certain blood cancers, is generating excitement in early tests against autoimmune diseases. Designed to wipe out a whole class of immune cells, the treatment holds promise but comes with potentially serious risks.
Embark on an epic journey to the Red Planet in this stunning 3D animated story of an imaginary SpaceX mission to Mars in 2030! 🚀🌌 This creative visualization brings to life the excitement, challenges, and triumphs of humanity’s quest to explore our planetary neighbor.
From the dramatic rocket launch to breathtaking Martian landscapes, every detail in this video reflects pure imagination and creativity. While inspired by SpaceX’s innovative spirit, this animation is a fictional take and may not align with real-life specifications or plans.
Continue reading “SPACEX MARS MISSION #spacex #starship #marsmission” »
Scientists made a major advancement in X-ray science by creating high-power attosecond hard X-ray pulses with megahertz repetition rates, allowing for ultrafast electron dynamics study and atomic-level non-destructive measurements.
These pulses are significant due to their ability to capture quick electron movements, leading to potential applications in attosecond crystallography and transformative impacts across various scientific disciplines.
Breakthrough in X-Ray Pulse Technology.
The more exciting, transformative, and revolutionary a science result appears, especially coming out of nowhere, the more likely it is to be dead wrong. So, approach science headlines with a healthy amount of skepticism and patience.
By Paul Sutter
KAIST researchers have developed a groundbreaking single-atom editing technology using light-powered “molecular scissors” to convert oxygen atoms into nitrogen in drug compounds, simplifying drug development and boosting efficacy.
In the field of pioneering drug development, a groundbreaking new technology that enables the precise and rapid editing of key atoms critical to drug efficacy has been hailed as a transformative and “dream” innovation, revolutionizing the process of discovering potential drug candidates. Researchers at KAIST have achieved a world-first by successfully developing single-atom editing technology designed to maximize drug efficacy.
On October 8th, KAIST (represented by President Kwang-Hyung Lee) announced that Professor Yoonsu Park’s research team from the Department of Chemistry successfully developed technology that enables the easy editing and correction of oxygen atoms in furan compounds into nitrogen atoms, directly converting them into pyrrole frameworks, which are widely used in pharmaceuticals.
Dysolve, the first artificial intelligence-powered platform for dissolving dyslexia and associated learning disabilities, is paving the way for a new treatment approach.
Dyslexia is a neurodevelopmental learning disorder that makes it challenging for children and adults to read, write, and spell. The condition affects one out of every five people and represents 80% to 90% of those with learning disabilities.
Continue reading “AI-Powered Software Offers Breakthrough for Treating Dyslexia” »
